To Ablate or Not to Ablate: Issues and Evidence Involved in 131I Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma-Reference-Cited by-同舟云学术

To Ablate or Not to Ablate: Issues and Evidence Involved in 131I Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma

Published:2011-03 Issue:2 Volume:41 Page:96-104
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Goldsmith Stanley J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference21 articles.

1. Radioiodine and thyroid disease: The beginning;Becker;Semin Nucl Med,1996

2. Radioactive iodine (I-131) in the postoperative treatment of thyroid cancer;Blahd;Cancer,1960

3. An analysis of “ablation of thyroid remnants” with I-131 in 511 patients from 1947-1984 J;Bierwaltes;Nucl Med,1984

4. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma;Mazzaferri;Thyroidology,1997

5. Papillary thyroid carcinoma managed at the Mayo clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients;Hay;World J Surg,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer;Hormones;2023-08-21

2. Cáncer de tiroides, redefiniendo la radioyodo-refractariedad (RAIR);Gaceta Mexicana de Oncolog�a;2021-10-21

3. Targeted Radionuclide Therapy: A Historical and Personal Review;Seminars in Nuclear Medicine;2020-01

4. Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment;Endocrine Journal;2020

5. Radioiodine Therapy in Differentiated Thyroid Carcinoma;The Thyroid and Its Diseases;2019